Share on LinkedInShare on LinkedIn

ARTICLE · 03 NOVEMBER 2009

IP Update - October, 2009

The U.S. Court of Appeals for the Federal Circuit invalidated claims for a method of treating Alzheimer’s disease because the specification comprised a summary of six scientific papers and reported no data on the use of the compound at issue in humans.

United StatesIntellectual Property

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from